Medicines for Smoking Cessation: Global Markets
|出版日||ページ情報||英文 119 Pages
This BCC Research report analyzes the global trends in smoking cessation. Public health departments and national regulatory agencies are working to create awareness on the health hazards of smoking. Their efforts are to educate, counsel and prevent people from smoking. Smoking cessation medications are used to help patients cope with the withdrawal symptoms of smoking and nicotine dependence and assist them in quitting smoking completely.
The objective of this study is to understand current market trends, future prospects and opportunities in nicotine dependence treatments. The report will assess the role of smoking cessation medicines in improving the quit rate. It will bring out the key result areas of smoking cessation medicines and will address the areas that need improvement.
The report covers developed and emerging markets in order to help readers understand:
Key information from published literature was used to conduct interviews with industry participants to validate and obtain expert opinions on current and future trends. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as to formulate market projections. All market data pertain to the manufacturer's level. Data are expressed in 2012 U.S. dollars. The base year was 2012. Historical data are provided for 2011 and forecast data are provided for 2013 and 2018. Historical, base year and forecast data are provided for each market segment and sub-segment. Market shares are provided for each market segment for the base year of 2012.